Study protocol: safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): a multicenter, open-label, single arm, phase II trial
2017 · BMC Pediatrics · 11 citations
https://doi.org/10.1186/s12887-017-0923-8